Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia

NCT03207724 is registered in ClinicalTrials.gov with Andrew Hendifar, MD as lead sponsor.

NCT NCT03207724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Onivyde and 5-FU in Combination With Xilonix for Advanced Pancreatic Cancer With Cachexia
Lead sponsor
Andrew Hendifar, MD
Phase
Phase 1
Overall status
Completed
Start date
October 16, 2017
Completion date
October 27, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, pancreatic cancer, weight loss